News
Vertex Pharmaceuticals (NasdaqGS:VRTX) presented promising clinical data on their CFTR modulator ALYFTREK at the European Cystic Fibrosis Conference, showcasing improved outcomes for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback